Suppr超能文献

通过 NMR 筛选和相似性搜索鉴定靶向 HIV-1 gp41 替代口袋的片段。

Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching.

机构信息

Department of Basic Sciences, College of Osteopathic Medicine, Touro University California, Mare Island, Vallejo, CA 94592, USA.

出版信息

Bioorg Med Chem Lett. 2013 Sep 15;23(18):5114-8. doi: 10.1016/j.bmcl.2013.07.026. Epub 2013 Jul 22.

Abstract

The HIV-1 envelope glycoprotein gp41 fusion intermediate is a promising drug target for inhibiting viral entry. However, drug development has been impeded by challenges inherent in mediating the underlying protein-protein interaction. Here we report on the identification of fragments that bind to a C-terminal sub-pocket adjacent to the well-known hydrophobic pocket on the NHR coiled coil. Using a specifically designed assay and ligand-based NMR screening of a fragment library, we identified a thioenylaminopyrazole compound with a dissociation constant of ~500 μM. Interaction with the C-terminal sub-pocket was confirmed by paramagnetic relaxation enhancement NMR experiments, which also yielded the binding mode. Shape-based similarity searching detected additional phenylpyrazole and phenyltriazole fragments within the library, enriching the hit rate over random screening, and revealing molecular features required for activity. Discovery of the novel scaffolds and binding mechanism suggests avenues for extending the interaction surface and improving the potency of a hydrophobic pocket binding inhibitor.

摘要

HIV-1 包膜糖蛋白 gp41 融合中间态是抑制病毒进入的有前途的药物靶点。然而,由于介导潜在的蛋白质-蛋白质相互作用所固有的挑战,药物开发受到了阻碍。在这里,我们报告了鉴定与 NHR 卷曲螺旋上众所周知的疏水性口袋相邻的 C 末端亚口袋结合的片段。我们使用专门设计的测定法和基于配体的 NMR 筛选文库,鉴定了一种具有~500 μM 离解常数的噻吩基氨基吡唑化合物。通过顺磁弛豫增强 NMR 实验证实了与 C 末端亚口袋的相互作用,该实验还确定了结合模式。基于形状的相似性搜索在文库中检测到其他的苯基吡唑和苯基三唑片段,这比随机筛选提高了命中率,并揭示了活性所需的分子特征。新骨架和结合机制的发现为扩展疏水性口袋结合抑制剂的相互作用表面和提高其效力提供了途径。

相似文献

1
Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching.
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5114-8. doi: 10.1016/j.bmcl.2013.07.026. Epub 2013 Jul 22.
3
Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.
ACS Chem Biol. 2011 Mar 18;6(3):267-74. doi: 10.1021/cb100368d. Epub 2011 Jan 7.
5
Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41.
Org Biomol Chem. 2017 Jun 28;15(24):5210-5219. doi: 10.1039/c7ob00954b. Epub 2017 Jun 7.
6
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):612-7. doi: 10.1016/j.bmcl.2009.11.076. Epub 2009 Nov 20.
7
Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
J Biol Chem. 2009 Feb 6;284(6):3619-27. doi: 10.1074/jbc.M809269200. Epub 2008 Dec 10.
9
10
Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.
PLoS One. 2013 May 31;8(5):e66156. doi: 10.1371/journal.pone.0066156. Print 2013.

引用本文的文献

1
Helical sulfonyl-γ-AApeptides for the inhibition of HIV-1 fusion and HIF-1α signaling.
RSC Med Chem. 2024 Mar 20;15(5):1418-1423. doi: 10.1039/d4md00110a. eCollection 2024 May 22.
4
N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.
Front Pharmacol. 2019 Aug 2;10:859. doi: 10.3389/fphar.2019.00859. eCollection 2019.
6
Mechanism of HIV-1 Resistance to an Electronically Constrained α-Helical Peptide Membrane Fusion Inhibitor.
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.02044-17. Print 2018 Apr 1.
8
Systematic Targeting of Protein-Protein Interactions.
Trends Pharmacol Sci. 2016 Aug;37(8):702-713. doi: 10.1016/j.tips.2016.05.008. Epub 2016 Jun 4.
9
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.
Curr HIV Res. 2016;14(3):283-94. doi: 10.2174/1570162x14999160224103908.

本文引用的文献

1
Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.
Chem Biol Drug Des. 2013 Jan;81(1):22-32. doi: 10.1111/cbdd.12066.
4
Using fragment-based technologies to target protein-protein interactions.
Curr Pharm Des. 2012;18(30):4685-96. doi: 10.2174/138161212802651689.
5
Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.
J Biol Chem. 2012 Jun 8;287(24):20281-9. doi: 10.1074/jbc.M112.354126. Epub 2012 Apr 16.
6
Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library.
Bioorg Med Chem Lett. 2012 Apr 15;22(8):2861-5. doi: 10.1016/j.bmcl.2012.02.062. Epub 2012 Mar 3.
7
Amphipathic properties of HIV-1 gp41 fusion inhibitors.
Curr Top Med Chem. 2011 Dec;11(24):3022-32. doi: 10.2174/156802611798808488.
8
Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.
J Med Chem. 2011 Oct 27;54(20):7220-31. doi: 10.1021/jm200791z. Epub 2011 Oct 3.
9
Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.
ACS Chem Biol. 2011 Mar 18;6(3):267-74. doi: 10.1021/cb100368d. Epub 2011 Jan 7.
10
Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41.
ChemMedChem. 2010 Nov 8;5(11):1813-24. doi: 10.1002/cmdc.201000289.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验